ADC Therapeutics - Time For A Turn-Around?
February 27, 2024 at 05:15 AM EST
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.